108 related articles for article (PubMed ID: 27547439)
1. First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort.
Ruiz-Irastorza G; Garcia M; Espinosa G; Caminal L; Mitjavila F; González-León R; Sopeña B; Canora J; Villalba MV; Rodríguez-Carballeira M; López-Dupla JM; Callejas JL; Castro A; Tolosa C; Sánchez-García ME; Pérez-Conesa M; Navarrete-Navarrete N; Rodríguez AP; Herranz MT; Pallarés L
Lupus Sci Med; 2016; 3(1):e000153. PubMed ID: 27547439
[TBL] [Abstract][Full Text] [Related]
2. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
González-Echavarri C; Capdevila O; Espinosa G; Suárez S; Marín-Ballvé A; González-León R; Rodríguez-Carballeira M; Fonseca-Aizpuru E; Pinilla B; Pallarés L; Ruiz-Irastorza G;
Lupus; 2018 Dec; 27(14):2253-2261. PubMed ID: 30451641
[TBL] [Abstract][Full Text] [Related]
3. Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis.
Ruiz-Arruza I; Barbosa C; Ugarte A; Ruiz-Irastorza G
Autoimmun Rev; 2015 Oct; 14(10):875-9. PubMed ID: 26044819
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.
Ruiz-Arruza I; Ugarte A; Cabezas-Rodriguez I; Medina JA; Moran MA; Ruiz-Irastorza G
Rheumatology (Oxford); 2014 Aug; 53(8):1470-6. PubMed ID: 24681836
[TBL] [Abstract][Full Text] [Related]
5. Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus.
Ruiz-Irastorza G; García M; Espinosa G; Cabezas-Rodríguez I; Mitjavila F; González-León R; Sopeña B; Perales I; Pinilla B; Rodríguez-Carballeira M; López-Dupla JM; Callejas JL; Castro A; Tolosa C; Sánchez-García ME; Pérez-Conesa M; Navarrete-Navarrete N; Rodríguez AP; Herranz MT; Pallarés L;
Clin Exp Rheumatol; 2016; 34(3):466-72. PubMed ID: 26940538
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics during diagnosis of a prospective cohort of patients with systemic lupus erythematosus treated in Spanish Departments of Internal Medicine: The RELES study.
Canora J; García M; Mitjavila F; Espinosa G; Suárez S; González-León R; Sopeña B; Boldova R; Castro A; Ruiz-Irastorza G;
Rev Clin Esp (Barc); 2017; 217(1):7-14. PubMed ID: 27793331
[TBL] [Abstract][Full Text] [Related]
7. Prednisone and long-term damage in systemic lupus erythematosus: Which is the threshold dose? A pilot study.
Danza A; Graña D; Soto E; Silveira G; Carlomagno A; Rebella M
Lupus; 2022 Jun; 31(7):880-884. PubMed ID: 35354060
[TBL] [Abstract][Full Text] [Related]
8. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
Meinão IM; Sato EI; Andrade LE; Ferraz MB; Atra E
Lupus; 1996 Jun; 5(3):237-41. PubMed ID: 8803897
[TBL] [Abstract][Full Text] [Related]
9. Damage in systemic lupus erythematosus and its association with corticosteroids.
Zonana-Nacach A; Barr SG; Magder LS; Petri M
Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870
[TBL] [Abstract][Full Text] [Related]
10. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
Galarza-Maldonado C; Kourilovitch MR; Molineros JE; Cardiel MH; Zurita L; Soroka NF; Yagur VY; Doukh N; Cervera R
Autoimmun Rev; 2010 Dec; 10(2):108-11. PubMed ID: 20804861
[TBL] [Abstract][Full Text] [Related]
11. Effects of low or medium-dose of prednisone on insulin resistance in patients with systemic lupus erythematosus.
Sabio JM; Vargas-Hitos JA; Navarrete N; Hidalgo-Tenorio C; Jiménez-Alonso J;
Clin Exp Rheumatol; 2010; 28(4):483-9. PubMed ID: 20497628
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus.
Sarkissian T; Beyene J; Feldman B; McCrindle B; Silverman ED
Arthritis Rheum; 2007 Feb; 56(2):631-8. PubMed ID: 17265498
[TBL] [Abstract][Full Text] [Related]
13. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
Carneiro JR; Sato EI
J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
[TBL] [Abstract][Full Text] [Related]
14. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
[TBL] [Abstract][Full Text] [Related]
15. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
Tseng CE; Buyon JP; Kim M; Belmont HM; Mackay M; Diamond B; Marder G; Rosenthal P; Haines K; Ilie V; Abramson SB
Arthritis Rheum; 2006 Nov; 54(11):3623-32. PubMed ID: 17075807
[TBL] [Abstract][Full Text] [Related]
16. Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study.
Inês L; Duarte C; Silva RS; Teixeira AS; Fonseca FP; da Silva JA
Rheumatology (Oxford); 2014 Jan; 53(1):85-9. PubMed ID: 24067885
[TBL] [Abstract][Full Text] [Related]
17. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage.
Brunner HI; Jones OY; Lovell DJ; Johnson AM; Alexander P; Klein-Gitelman MS
Lupus; 2003; 12(8):600-6. PubMed ID: 12945718
[TBL] [Abstract][Full Text] [Related]
18. Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA.
Collins CE; Dall'Era M; Kan H; Macahilig C; Molta C; Koscielny V; Chang DJ
Lupus Sci Med; 2016; 3(1):e000118. PubMed ID: 26835146
[TBL] [Abstract][Full Text] [Related]
19. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women.
Sinigaglia L; Varenna M; Binelli L; Zucchi F; Ghiringhella D; Gallazzi M; Limonta M; Zeni S; Fantini F
J Rheumatol; 1999 Jun; 26(6):1280-4. PubMed ID: 10381043
[TBL] [Abstract][Full Text] [Related]
20. Predictors of carotid atherosclerosis in systemic lupus erythematosus.
Maksimowicz-McKinnon K; Magder LS; Petri M
J Rheumatol; 2006 Dec; 33(12):2458-63. PubMed ID: 17014002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
